Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Summary Literature (5)
Literature for DOID 10283: prostate cancer


Xenbase Articles :
( Denotes literature images)
AGR2, an androgen-inducible secretory protein overexpressed in prostate cancer., Zhang JS,Gong A,Cheville JC,Smith DI,Young CY, Genes Chromosomes Cancer. July 1, 2005; 43(3):1045-2257.
Cloning and functional expression of a mouse gonadotropin-releasing hormone receptor., Tsutsumi M,Zhou W,Millar RP,Mellon PL,Roberts JL,Flanagan CA,Dong K,Gillo B,Sealfon SC, Mol Endocrinol. July 1, 1992; 6(7):1944-9917.
Discovery and characterization of a small molecule inhibitor of the PDZ domain of dishevelled., Grandy D,Shan J,Zhang X,Rao S,Akunuru S,Li H,Zhang Y,Zhang Y,Alpatov I,Zhang XA,Lang RA,Shi DL,Zheng JJ, J Biol Chem. June 12, 2009; 284(24):1083-351X.
Xenopus as a model system for the study of GOLPH2/GP73 function: Xenopus GOLPH2 is required for pronephros development., Li L,Wen L,Gong Y,Mei G,Liu J,Chen Y,Chen Y,Peng T, PLoS One. January 1, 2012; 7(6):1932-6203.
Overexpression of TPX2 is associated with progression and prognosis of prostate cancer., Zou J,Huang RY,Jiang FN,Chen DX,Wang C,Wang C,Wang C,Han ZD,Liang YX,Zhong WD, Oncol Lett. September 1, 2018; 16(3):1792-1074.